Impact of antiseizure medication with a very long half-life on long term video-EEG monitoring in focal epilepsy.

Epilepsy surgery is an effective treatment option for drug-resistant focal epilepsy (FE), provided that the patient is a suitable candidate for the procedure [1]. Typically, individuals undergo evaluation in an Epilepsy Monitoring Unit (EMU) to determine their eligibility for surgery [2]. Long term Video-EEG monitoring (LTM) is an essential component of this presurgical evaluation [3]. The goal is to capture several seizures to verify that they are stereotypical and that the epilepsy is unifocal [4].

Seguir leyendo →
0

Neuroimaging correlation with EEG in status epilepticus

Status epilepticus (SE) is a life-threating condition with overall mortality approaching 20%, in which generalized convulsive status epilepticus (CSE) represents about 45–74% of all cases. [1,2] SE was originally defined as recurrent seizures without recovery between seizure activities or a seizure with 5 minutes or more of continuous clinical seizure with or without electrographic seizure activity; although, it was not practical in real clinical settings. In 2015, the International League Against Epilepsy proposed a new definition of SE: 5 minutes ...

Seguir leyendo →
0

Early Prediction of Drug-Resistant Epilepsy using Clinical and EEG Features Based on Convolutional Neural Network

Epilepsy is a spontaneous and serious neurological disorder that presents with recurrent seizures and affects around 50 million people globally [1]. Unfortunately, despite recent advances in the development of antiseizure medications (ASMs), drug-resistant epilepsy (DRE) still affects 20% to 30% of patients with epilepsy (PWE) [1–3]. Patients with DRE bear significant economic, social, physical, and psychological burdens, but it takes a long time to identify DRE after repetitive ASMs trial, identifying patients at high risk of developing DRE early may ...

Seguir leyendo →
0

Clinical phenotype and genetic characteristics of SZT2 related diseases: A case report and literature review

Seizure threshold 2 protein homolog gene (SZT2, MIM: 615463) is located on Chr1 p34.2. It is mainly expressed in the parietal lobe, frontal cortex, hippocampus, cerebellum and dorsal root ganglia of the central nervous system, and encodes a 3375 amino acid protein [1]. SZT2 protein is located in the lysosome and (together with KPTN, ITFG2, and C12orf66) forms the KICSTOR protein complex [2], which is a negative regulator of the rapamycin complex signaling pathway [3,4]. The over-activation of the rapamycin ...

Seguir leyendo →
0

Predicting the cause of seizures using features extracted from interactions with a virtual agent

Transient Loss of Consciousness (TLOC) is a time-limited loss of awareness characterised by abnormal motor control, loss of responsiveness, amnesia, and a complete recovery. Over 90% of TLOC presentations are explained by epilepsy, functional/dissociative seizures (FDS) or syncope [5]. A thorough analysis of the medical history by an expert is currently the most effective differential diagnostic method [21] because patients are typically asymptomatic on presentation and investigations after the event are of limited value.

Seguir leyendo →
0

Safety & Feasibility of Responsive Neurostimulation in Children with Refractory Epilepsy: A Single-Center Experience

Responsive Neurostimulation (RNS) is a relatively recent addition to the epilepsy surgery armory, gaining FDA approval in 2013 for use in adults with intractable focal epilepsy [1]. There have been at least 9 years of data evaluating the safety and efficacy in adult patients [2]. RNS is not yet approved for use in Europe, or for pediatric patients less than 18 years of age in the United States. Options of neurostimulation include vagus nerve stimulation (VNS), responsive neurostimulation, deep brain ...

Seguir leyendo →
0

EFHC1 gene mutation profile of Turkish JME patients and its association with disease risk

Juvenile myoclonic epilepsy (JME) is one of the most common epilepsy syndromes among the genetic generalized epilepsies (GGEs). Although it has been described using different names for many years, it was most recently defined in 1989 by the International League Against Epilepsy (ILAE) as an epilepsy syndrome usually seen in adolescents that is characterized by seizures with bilateral, single or repetitive, arrhythmic, irregular myoclonic jerks (predominantly in the upper limbs) without loss of consciousness during jerks.

Seguir leyendo →
0
Página 8 de 181 «...678910...»